Concepedia

Kevin Kong

KK

Statistics

Publications

6

Citations

117

H-Index

6

Active since

2003

Affiliations

University of California, Irvine(Current)

Kevin Kong is an author at University of California, Irvine specializing in oncology, medicine, and pharmacology.

Top concepts

Publications per year

2003–2022

6

Publications

6

Stevens–Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine

Karen R. Sommers, Kevin Kong, Dang T. Bui et al. · Anti-Cancer Drugs · 2003 · 44 citations

Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer

Jane Choi, Kevin Kong, Tahseen Mozaffar et al. · Anti-Cancer Drugs · 2005 · 28 citations

, , +13

Combined topoisomerase I inhibition for the treatment of metastatic colon cancer

Randall F. Holcombe, Kevin Kong, Donna Wimmer · Anti-Cancer Drugs · 2004 · 13 citations

, , +12

Multiple joint effusions associated with high‐dose imatinib therapy in a patient with chronic myelogenous leukaemia

James C. Moore, Carolyn Dennehey, Arash Anavim et al. · European Journal Of Haematology · 2006 · 12 citations

Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma

Zeynep Eroglu, Kevin Kong, James G. Jakowatz et al. · Cancer Chemotherapy and Pharmacology · 2011 · 10 citations · Full text

1–5 of 6